Kano, Y.; Kataoka, N.; Kunimatsu, Y.; Tsutsumi, R.; Sato, I.; Tanimura, M.; Nakano, T.; Tanimura, K.; Takeda, T.
Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report. Medicina 2022, 58, 706.
https://doi.org/10.3390/medicina58060706
AMA Style
Kano Y, Kataoka N, Kunimatsu Y, Tsutsumi R, Sato I, Tanimura M, Nakano T, Tanimura K, Takeda T.
Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report. Medicina. 2022; 58(6):706.
https://doi.org/10.3390/medicina58060706
Chicago/Turabian Style
Kano, Yukari, Nobutaka Kataoka, Yusuke Kunimatsu, Rei Tsutsumi, Izumi Sato, Mai Tanimura, Takayuki Nakano, Keiko Tanimura, and Takayuki Takeda.
2022. "Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report" Medicina 58, no. 6: 706.
https://doi.org/10.3390/medicina58060706
APA Style
Kano, Y., Kataoka, N., Kunimatsu, Y., Tsutsumi, R., Sato, I., Tanimura, M., Nakano, T., Tanimura, K., & Takeda, T.
(2022). Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report. Medicina, 58(6), 706.
https://doi.org/10.3390/medicina58060706